<a href="https://laohu8.com/S/DH">Definitive Healthcare Corp.</a> Announces Inducement Award of 830,565 RSUs to New Chief Commercial Officer Tina Hannagan
FRAMINGHAM, Mass., June 03, 2025 - Definitive Healthcare Corp. (Nasdaq: DH) has announced the approval of an inducement award for its newly appointed Chief Commercial Officer, Tina Hannagan. The award, granted by the Human Capital Management and Compensation Committee of the company's Board of Directors, consists of 830,565 time-based restricted stock units (RSUs), effective June 1, 2025. The award was individually negotiated and aligns with Nasdaq Listing Rule 5635(c)(4), serving as an inducement material to Ms. Hannagan's employment commencement. Under the terms of Definitive Healthcare's 2023 Inducement Plan, 25% of the RSUs are set to vest on June 1, 2026, with the remaining RSUs vesting in quarterly installments of 6.25% over the following three years, contingent upon Ms. Hannagan's continued employment with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definitive Healthcare Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9462188-en) on June 03, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。